|Bid||25.70 x 1400|
|Ask||26.96 x 800|
|Day's range||25.94 - 26.69|
|52-week range||23.09 - 42.48|
|Beta (5Y monthly)||0.99|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
It hasn't been the best quarter for Arrowhead Pharmaceuticals, Inc. ( NASDAQ:ARWR ) shareholders, since the share price...
Key Insights Significantly high institutional ownership implies Arrowhead Pharmaceuticals' stock price is sensitive to...
Arrowhead Pharmaceuticals ( NASDAQ:ARWR ) Second Quarter 2023 Results Key Financial Results Revenue: US$146.3m (down...